ABSTRACT
The specifications for a finished pharmaceutical product are an approved list of tests and associated acceptance criteria that is expected of a product at batch release and throughout its shelf life. The International Council for Harmonisation (ICH) Q6A provides a suitable working definition of specifications for a new 978drug substances or product that can also be applied to marketed products [1].
